Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein EURL homolog (C21orf91) is a multifunctional gene product with pivotal roles in neural progenitor proliferation, neuronal differentiation, and dendritic spine formation in the developing cerebral cortex, with relevance to neurodevelopmental disorders such as Down Syndrome. It acts as a molecular hub, influencing cellular fate (e.g., differentiation of oligodendroglial cells and glial population balance), modulating inflammatory signaling pathways (notably affecting NF-κB activity in hepatocellular carcinoma), affecting susceptibility to viral infections (herpes simplex labialis), and contributing to tumor phenotype regulation in melanocytic neoplasms. C21orf91 is not classified as a receptor, enzyme, or common drug target; instead, it is an emerging molecular modulator with broad impact on disease pathogenesis and cellular development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein EURL homolog (C21orf91).